UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000013625
Receipt No. R000013512
Scientific Title Efficacy of bepotastine besilate for seasonal allergic rhinitis patients - about laryngeal symptoms, olfactory disorder, sleep disorder, QOL and symptoms caused by Asian sand dust
Date of disclosure of the study information 2014/04/04
Last modified on 2021/04/16 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Efficacy of bepotastine besilate for seasonal allergic rhinitis patients - about laryngeal symptoms, olfactory disorder, sleep disorder, QOL and symptoms caused by Asian sand dust
Acronym Efficacy of bepotastine besilate for seasonal allergic rhinitis patients
Scientific Title Efficacy of bepotastine besilate for seasonal allergic rhinitis patients - about laryngeal symptoms, olfactory disorder, sleep disorder, QOL and symptoms caused by Asian sand dust
Scientific Title:Acronym Efficacy of bepotastine besilate for seasonal allergic rhinitis patients
Region
Japan

Condition
Condition Seasonal allergic rhinitis
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Efficacy of bepotastine besilate forseasonal allergic rhinitis
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Nasal symptoms, nasal findings, laryngeal symptoms, laryngeal findings, olfactory disorder, sleep disorder, QOL, and symptoms caused by Asian sand dust
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Bepotastine besilate
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male
Key inclusion criteria Seasonal allergic rhinitis patients who come us including related hospitals
Key exclusion criteria Patients with using any other antiallergic medicine or immunotherapy.
Target sample size 50

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kensei Naito
Organization Fujita Health University
Division name Otorhinoralyngology
Zip code
Address 1-98 Denngakugakubo, Kutukake-cho, Toyoake city, Aichi Prefecture
TEL 0562-93-9291
Email knaito@fujita-hu.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Tomoaki Murashima
Organization Fujita Health University
Division name Otorhinoralyngology
Zip code
Address 1-98 Denngakugakubo, Kutukake-cho, Toyoake city, Aichi Prefecture
TEL 0562-93-9291
Homepage URL
Email abc2-and@fujita-hu.ac.jp

Sponsor
Institute Fujita Health University
Institute
Department

Funding Source
Organization Fujita Health University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 04 Month 04 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 12 Month 24 Day
Date of IRB
2014 Year 01 Month 15 Day
Anticipated trial start date
2014 Year 01 Month 15 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
2016 Year 03 Month 31 Day
Date trial data considered complete
2016 Year 03 Month 31 Day
Date analysis concluded
2016 Year 03 Month 31 Day

Other
Other related information

Management information
Registered date
2014 Year 04 Month 04 Day
Last modified on
2021 Year 04 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013512